HKD 0.06
(-3.23%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -337.41 Million HKD | -21.75% |
2022 | -277.13 Million CNY | -8.75% |
2021 | -254.84 Million CNY | -19.13% |
2020 | -213.92 Million CNY | 24.25% |
2019 | -282.42 Million CNY | -796.45% |
2018 | -31.5 Million CNY | 9.61% |
2017 | -34.85 Million CNY | 93.08% |
2016 | -503.54 Million CNY | 45.19% |
2015 | -918.75 Million CNY | 4.95% |
2014 | -966.56 Million CNY | -12.58% |
2013 | -858.57 Million CNY | -33.55% |
2012 | -642.87 Million CNY | 8.89% |
2011 | -705.59 Million CNY | -1148.87% |
2010 | -56.49 Million CNY | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -305.47 Million CNY | 0.0% |
2023 Q2 | -339.96 Million CNY | 0.0% |
2023 Q4 | -337.41 Million HKD | 0.0% |
2023 FY | -337.41 Million HKD | -21.75% |
2022 Q2 | -122.63 Million CNY | 0.0% |
2022 FY | -277.13 Million CNY | -8.75% |
2022 Q4 | -277.13 Million CNY | 0.0% |
2021 Q4 | -208.99 Million CNY | 0.0% |
2021 Q2 | -152.8 Million CNY | 0.0% |
2021 FY | -254.84 Million CNY | -19.13% |
2020 Q2 | -269.45 Million CNY | 0.0% |
2020 FY | -213.92 Million CNY | 24.25% |
2020 Q4 | -180.12 Million CNY | 0.0% |
2019 FY | -282.42 Million CNY | -796.45% |
2019 Q2 | 18.87 Million CNY | 0.0% |
2019 Q4 | -282.42 Million CNY | 0.0% |
2018 FY | -31.5 Million CNY | 9.61% |
2018 Q2 | 23.04 Million CNY | 0.0% |
2018 Q4 | -31.5 Million CNY | 0.0% |
2017 Q4 | -34.85 Million CNY | 0.0% |
2017 Q2 | -209.64 Million CNY | 0.0% |
2017 FY | -34.85 Million CNY | 93.08% |
2016 Q4 | -503.54 Million CNY | 0.0% |
2016 Q2 | -840.94 Million CNY | 0.0% |
2016 FY | -503.54 Million CNY | 45.19% |
2015 FY | -918.75 Million CNY | 4.95% |
2015 Q4 | -918.75 Million CNY | 0.0% |
2015 Q2 | -963.49 Million CNY | 0.0% |
2014 Q2 | -902.17 Million CNY | 0.0% |
2014 FY | -966.56 Million CNY | -12.58% |
2014 Q4 | -966.56 Million CNY | 0.0% |
2013 Q2 | -767.69 Million CNY | 0.0% |
2013 Q4 | -858.57 Million CNY | 0.0% |
2013 FY | -858.57 Million CNY | -33.55% |
2012 Q2 | -675.87 Million CNY | 0.0% |
2012 Q4 | -642.87 Million CNY | 0.0% |
2012 FY | -642.87 Million CNY | 8.89% |
2011 Q4 | -705.59 Million CNY | 0.0% |
2011 Q2 | -69.23 Million CNY | 0.0% |
2011 FY | -705.59 Million CNY | -1148.87% |
2010 FY | -56.49 Million CNY | 0.0% |
2010 Q4 | -56.49 Million CNY | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 27.54 Million HKD | 1325.007% |
Innovative Pharmaceutical Biotech Limited | 914.37 Million HKD | 136.901% |
China Overseas Nuoxin International Holdings Limited | 9.99 Million HKD | 3477.199% |
Huasheng International Holding Limited | 175.03 Million HKD | 292.768% |
Fourace Industries Group Holdings Limited | -250.33 Million HKD | -34.787% |
Evergreen Products Group Limited | 430.83 Million HKD | 178.317% |
EC Healthcare | 1.05 Billion HKD | 132.133% |
Ming Fai International Holdings Limited | -329.49 Million HKD | -2.406% |
Blue Moon Group Holdings Limited | -4.18 Billion HKD | 91.935% |
SuperRobotics Holdings Limited | 126.44 Million HKD | 366.856% |
Takbo Group Holdings Limited | -175.44 Million HKD | -92.326% |
Hyfusin Group Holdings Limited | -318.4 Million HKD | -5.969% |